Innate Pharma SA (IPHA) Gross margin
Innate Pharma SA (IPHA) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to IPHASource: SEC XBRL filings · For reference only · Not investment advice
More IPHA financial trends
IPHA RevenueIPHA Net incomeIPHA Net marginIPHA Gross profitIPHA Operating incomeIPHA Operating marginIPHA Operating cash flowIPHA Free cash flowIPHA Capital expendituresIPHA Return on equityIPHA Stock buybacksIPHA Dividends paidIPHA Total assetsIPHA Total liabilitiesIPHA Shareholders’ equityIPHA overview →